Skip to main content
. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504

Figure 2. Overview of apheresis therapies.

Figure 2

Plasma exchange and immunoadsorption were applied at similar frequencies for escalation from first- to fifth-line treatment (A) and for various clinical manifestations (B) of NMOSD attacks. The chi-square test was used for statistical analysis. IA = immunoadsorption; MY = myelitis; ON = optic neuritis; PE = plasma exchange.